MRD Monitoring in Acute Lymphoblastic Leukemia
0 vistas
administrator
06/15/23
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Mostrar más
Comentarios de Facebook
No se encontraron comentarios